Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1983-05-27
1986-12-23
Schwartz, Richard A.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
548336, A61K 31415, C07D40306
Patent
active
046312897
ABSTRACT:
A compound of formula I ##STR1## in which formula: R.sub.1 represents hydrogen or an alkyl group;
REFERENCES:
patent: 4241060 (1980-12-01), Smithen
patent: 4282232 (1981-08-01), Agrawal
Stratford, Int. J. Radiation Biol. Phys., vol. 8, 391-392, (1982).
Smith et al., Chemical Abstracts, vol. 95 (1981) No. 17999S.
Cancer-vol. 48 No. 3, Aug. 1, 1981--American Cancer Society, Inc. J. P. Lippincott Company,--696-707.
Hypoxia Mediated Radiation and Chemo-Sensitizing Drugs Br. J. Cancer (1984), 50, 285-289.
Radiation Sensitization and Chemopotentiation: RSU 1069, a Compound More Efficient Than Misonidazole=Br. J. Cancer (1984) 49, 571-577.
Adams Gerald E.
Ahmed Israr
Gibson David
Stratford Ian J.
Briscoe Kurt G.
National Research Development Corporation
Schwartz Richard A.
LandOfFree
Useful in radiotherapy of chemotherapy 4-aziridino-1-nitroimidaz does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Useful in radiotherapy of chemotherapy 4-aziridino-1-nitroimidaz, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Useful in radiotherapy of chemotherapy 4-aziridino-1-nitroimidaz will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-171988